resource source identifier antibodies rabbit anti cul4a bethyl laboratories cat Search Results


93
Bethyl rabbit anti cul4a antibody
Rabbit Anti Cul4a Antibody, supplied by Bethyl, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti cul4a antibody/product/Bethyl
Average 93 stars, based on 1 article reviews
rabbit anti cul4a antibody - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
Cell Signaling Technology Inc rabbit anti cul4a nature
Rabbit Anti Cul4a Nature, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti cul4a nature/product/Cell Signaling Technology Inc
Average 93 stars, based on 1 article reviews
rabbit anti cul4a nature - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
Bethyl a300 739a
A300 739a, supplied by Bethyl, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/a300 739a/product/Bethyl
Average 93 stars, based on 1 article reviews
a300 739a - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc resource source identifier antibodies rabbit polyclonal anti cul4a
Figure 1. A Toolbox to Monitor Endogenous CRL4 Complexes Schematic representation of the PIKES approach: (1) 293T/17 cells were genetically engineered to carry a 3xFLAG or 3xHA on <t>Cul4A</t> or <t>Cul4B</t> or both to enable rapid and efficient (2) immunoprecipitation of endogenous CRL4 assemblages. (3) Endogenous CRL4 ligase complexes were then evaluated systematically using global and targeted proteomic approaches. First, the protein interaction network of interest was analyzed at endogenous protein levels, followed by a kinetic characterization of interactions, and the development of chemical and biochemical methods to control and preserve the composition of protein complexes. Subsequently, the cellular concentrations and complex stoichiometries were analyzed using QconCAT standards, and induced changes in complex composition were monitored quantitatively. See also Figures S1, S7, and S8.
Resource Source Identifier Antibodies Rabbit Polyclonal Anti Cul4a, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/resource source identifier antibodies rabbit polyclonal anti cul4a/product/Cell Signaling Technology Inc
Average 95 stars, based on 1 article reviews
resource source identifier antibodies rabbit polyclonal anti cul4a - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

93
Proteintech cul4a
Lgl physically interacts with VprBP and DDB1 independently of <t>Cul4A.</t> (A) Lgl2 was immunoprecipitated from lysate prepared from confluently cultured MDCK cells. VprBP and DDB1 were coprecipitated with Lgl2, along with aPKC and PAR6β. (B) VprBP was immunoprecipitated from lysate prepared from confluently cultured MDCK cells. Lgl2, Lgl1, DDB1, and <t>Cul4A</t> were coprecipitated with VprBP, whereas aPKC and PAR6β were not. (C) VprBP was immunoprecipitated from control and Lgl1/2 KD MDCK cell lysate. Coimmunoprecipitation of Cul4A was up-regulated by depletion of Lgl1/2. (D) V5-VprBP deletion mutants and HA-Lgl2 were coexpressed in HEK293T cells. Immunoprecipitation was performed using anti-V5 antibody conjugated resin. Asterisk indicates the 110-kDa bands that were reproducibly detected in this experiment. VprBP may have an endo-cleavage site around amino acid 964. (E) Schematic representation of VprBP mutants and results of the experiment performed in D. Numbers in the left column represent amino acid number. Asterisk indicates position of amino acid 964. The binding site of Merlin, reported in Li et al. (2010) , is also illustrated. (F) VprBP was immunoprecipitated from the lysates of HEK293T cells transfected with SBP-Lgl2 expression vector (lanes 2 and 4) or SBP expression vector (lanes 1 and 3). Note that the amount of Cul4A coimmunoprecipitated with VprBP was significantly decreased by expression of Lgl2. (G) Coimmunoprecipitated DDB1 and Cul4A were quantified by densitometry, and the average of three independent experiments is plotted. Error bars indicate ±SD. Double asterisks denotes significant difference ( p < 0.01) by Student's t test. (H) VprBP or Cdt2 was immunoprecipitated from the common lysate of HEK293T cells transfected with SBP-Lgl2 expression vector (lanes 2, 4, 6, and 8) and also immunoprecipitated from the common lysate of cells transfected with SBP expression vector (lanes 1, 3, 5, and 7). Long-exposure image is also presented for Cul4A-immunoblot. (I) Hypothetical model for CRL4 [VprBP] and Lgl-VprBP-DDB1 complex. Lgl2 may sterically mask the Cul4A-binding domain of DDB1.
Cul4a, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cul4a/product/Proteintech
Average 93 stars, based on 1 article reviews
cul4a - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
Bethyl resource source identifier antibodies rabbit polyclonal anti cul4a
Figure 1. A Toolbox to Monitor Endogenous CRL4 Complexes Schematic representation of the PIKES approach: (1) 293T/17 cells were genetically engineered to carry a 3xFLAG or 3xHA on <t>Cul4A</t> or <t>Cul4B</t> or both to enable rapid and efficient (2) immunoprecipitation of endogenous CRL4 assemblages. (3) Endogenous CRL4 ligase complexes were then evaluated systematically using global and targeted proteomic approaches. First, the protein interaction network of interest was analyzed at endogenous protein levels, followed by a kinetic characterization of interactions, and the development of chemical and biochemical methods to control and preserve the composition of protein complexes. Subsequently, the cellular concentrations and complex stoichiometries were analyzed using QconCAT standards, and induced changes in complex composition were monitored quantitatively. See also Figures S1, S7, and S8.
Resource Source Identifier Antibodies Rabbit Polyclonal Anti Cul4a, supplied by Bethyl, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/resource source identifier antibodies rabbit polyclonal anti cul4a/product/Bethyl
Average 93 stars, based on 1 article reviews
resource source identifier antibodies rabbit polyclonal anti cul4a - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

90
Bethyl immunohistochemistry ihc
Figure 1. A Toolbox to Monitor Endogenous CRL4 Complexes Schematic representation of the PIKES approach: (1) 293T/17 cells were genetically engineered to carry a 3xFLAG or 3xHA on <t>Cul4A</t> or <t>Cul4B</t> or both to enable rapid and efficient (2) immunoprecipitation of endogenous CRL4 assemblages. (3) Endogenous CRL4 ligase complexes were then evaluated systematically using global and targeted proteomic approaches. First, the protein interaction network of interest was analyzed at endogenous protein levels, followed by a kinetic characterization of interactions, and the development of chemical and biochemical methods to control and preserve the composition of protein complexes. Subsequently, the cellular concentrations and complex stoichiometries were analyzed using QconCAT standards, and induced changes in complex composition were monitored quantitatively. See also Figures S1, S7, and S8.
Immunohistochemistry Ihc, supplied by Bethyl, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/immunohistochemistry ihc/product/Bethyl
Average 90 stars, based on 1 article reviews
immunohistochemistry ihc - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Santa Cruz Biotechnology mouse monoclonal anti-cul1
Figure 1. A Toolbox to Monitor Endogenous CRL4 Complexes Schematic representation of the PIKES approach: (1) 293T/17 cells were genetically engineered to carry a 3xFLAG or 3xHA on <t>Cul4A</t> or <t>Cul4B</t> or both to enable rapid and efficient (2) immunoprecipitation of endogenous CRL4 assemblages. (3) Endogenous CRL4 ligase complexes were then evaluated systematically using global and targeted proteomic approaches. First, the protein interaction network of interest was analyzed at endogenous protein levels, followed by a kinetic characterization of interactions, and the development of chemical and biochemical methods to control and preserve the composition of protein complexes. Subsequently, the cellular concentrations and complex stoichiometries were analyzed using QconCAT standards, and induced changes in complex composition were monitored quantitatively. See also Figures S1, S7, and S8.
Mouse Monoclonal Anti Cul1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse monoclonal anti-cul1/product/Santa Cruz Biotechnology
Average 90 stars, based on 1 article reviews
mouse monoclonal anti-cul1 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

93
Bethyl cul4a
Figure 1. A Toolbox to Monitor Endogenous CRL4 Complexes Schematic representation of the PIKES approach: (1) 293T/17 cells were genetically engineered to carry a 3xFLAG or 3xHA on <t>Cul4A</t> or <t>Cul4B</t> or both to enable rapid and efficient (2) immunoprecipitation of endogenous CRL4 assemblages. (3) Endogenous CRL4 ligase complexes were then evaluated systematically using global and targeted proteomic approaches. First, the protein interaction network of interest was analyzed at endogenous protein levels, followed by a kinetic characterization of interactions, and the development of chemical and biochemical methods to control and preserve the composition of protein complexes. Subsequently, the cellular concentrations and complex stoichiometries were analyzed using QconCAT standards, and induced changes in complex composition were monitored quantitatively. See also Figures S1, S7, and S8.
Cul4a, supplied by Bethyl, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cul4a/product/Bethyl
Average 93 stars, based on 1 article reviews
cul4a - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

90
Bethyl ddb1 antibody
Figure 1. A Toolbox to Monitor Endogenous CRL4 Complexes Schematic representation of the PIKES approach: (1) 293T/17 cells were genetically engineered to carry a 3xFLAG or 3xHA on <t>Cul4A</t> or <t>Cul4B</t> or both to enable rapid and efficient (2) immunoprecipitation of endogenous CRL4 assemblages. (3) Endogenous CRL4 ligase complexes were then evaluated systematically using global and targeted proteomic approaches. First, the protein interaction network of interest was analyzed at endogenous protein levels, followed by a kinetic characterization of interactions, and the development of chemical and biochemical methods to control and preserve the composition of protein complexes. Subsequently, the cellular concentrations and complex stoichiometries were analyzed using QconCAT standards, and induced changes in complex composition were monitored quantitatively. See also Figures S1, S7, and S8.
Ddb1 Antibody, supplied by Bethyl, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ddb1 antibody/product/Bethyl
Average 90 stars, based on 1 article reviews
ddb1 antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Thermo Fisher alexa 594 goat anti-rabbit
Figure 1. A Toolbox to Monitor Endogenous CRL4 Complexes Schematic representation of the PIKES approach: (1) 293T/17 cells were genetically engineered to carry a 3xFLAG or 3xHA on <t>Cul4A</t> or <t>Cul4B</t> or both to enable rapid and efficient (2) immunoprecipitation of endogenous CRL4 assemblages. (3) Endogenous CRL4 ligase complexes were then evaluated systematically using global and targeted proteomic approaches. First, the protein interaction network of interest was analyzed at endogenous protein levels, followed by a kinetic characterization of interactions, and the development of chemical and biochemical methods to control and preserve the composition of protein complexes. Subsequently, the cellular concentrations and complex stoichiometries were analyzed using QconCAT standards, and induced changes in complex composition were monitored quantitatively. See also Figures S1, S7, and S8.
Alexa 594 Goat Anti Rabbit, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/alexa 594 goat anti-rabbit/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
alexa 594 goat anti-rabbit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Figure 1. A Toolbox to Monitor Endogenous CRL4 Complexes Schematic representation of the PIKES approach: (1) 293T/17 cells were genetically engineered to carry a 3xFLAG or 3xHA on Cul4A or Cul4B or both to enable rapid and efficient (2) immunoprecipitation of endogenous CRL4 assemblages. (3) Endogenous CRL4 ligase complexes were then evaluated systematically using global and targeted proteomic approaches. First, the protein interaction network of interest was analyzed at endogenous protein levels, followed by a kinetic characterization of interactions, and the development of chemical and biochemical methods to control and preserve the composition of protein complexes. Subsequently, the cellular concentrations and complex stoichiometries were analyzed using QconCAT standards, and induced changes in complex composition were monitored quantitatively. See also Figures S1, S7, and S8.

Journal: Molecular cell

Article Title: PIKES Analysis Reveals Response to Degraders and Key Regulatory Mechanisms of the CRL4 Network.

doi: 10.1016/j.molcel.2019.12.013

Figure Lengend Snippet: Figure 1. A Toolbox to Monitor Endogenous CRL4 Complexes Schematic representation of the PIKES approach: (1) 293T/17 cells were genetically engineered to carry a 3xFLAG or 3xHA on Cul4A or Cul4B or both to enable rapid and efficient (2) immunoprecipitation of endogenous CRL4 assemblages. (3) Endogenous CRL4 ligase complexes were then evaluated systematically using global and targeted proteomic approaches. First, the protein interaction network of interest was analyzed at endogenous protein levels, followed by a kinetic characterization of interactions, and the development of chemical and biochemical methods to control and preserve the composition of protein complexes. Subsequently, the cellular concentrations and complex stoichiometries were analyzed using QconCAT standards, and induced changes in complex composition were monitored quantitatively. See also Figures S1, S7, and S8.

Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Rabbit polyclonal anti-Cul4A (epitope Cell Signaling Technology 2699S, RRID:AB_2086563 Rabbit polyclonal anti-Cul4B (epitope AA Bethyl A303-863A, RRID:AB_2620214 Rabbit polyclonal anti-Cul4B (epitope AA Sigma-Aldrich C9995, RRID:AB_1840781 Mouse monoclonal anti-Cul1 (D-5) Santa Cruz Biotechnology Sc-17775, RRID:AB_627325 Rabbit polyclonal anti-Cand1 Bethyl A302-901A, RRID:AB_10663486 Rabbit monoclonal anti-DDB2 Abcam ab181136 Rabbit monoclonal anti-DDB1 Abcam ab109027, RRID:AB_10859111 Rabbit polyclonal anti-pCHK-1 Cell Signaling Technology 2341S, RRID:AB_330023 Rabbit polyclonal anti-pH2A.x Cell Signaling Technology 2577S, RRID:AB_2118010 Rabbit polyclonal anti-CRBN Sigma-Aldrich HPA045910-100UL, RRID:AB_10960409 Rabbit polyclonal anti-CSN5 Santa Cruz Biotechnology Sc-393725 Rat monoclonal anti-HA-HRP (clone 3F10) Roche 34071100 Mouse monoclonal anti-FLAG Sigma-Aldrich A8592-2MG, RRID:AB_439702 Mouse monoclonal anti-GAPDH Santa Cruz Biotechnology sc-365062, RRID:AB_10847862 Rabbit monoclonal anti-BRD4 Abcam ab128874, RRID:AB_11145462 Rabbit monoclonal anti-CK1alpha Abcam ab206662 Rabbit polyclonal anti-ZFP91 Bethyl A303-245A, RRID:AB_10953803 Rabbit polyclonal anti-RBM39 Bethyl A300-291A, RRID:AB_263411 Mouse monoclonlal anti-b-actin Sigma-Aldrich A5316, RRID:AB_476743 Rabbit monoclonal anti-GFP Abcam ab32146, RRID:AB_732717 Rabbit TrueBlot Anti-Rabbit IgG HRP Rockland 18-8816-33, RRID:AB_2610848 Donkey-anti-Mouse-HRP secondary antibody Jackson Laboratories 715-035-151, RRID:AB_2340771 Donkey anti-Rabbit-HRP secondary antibody Jackson Laboratories 711-035-152, RRID:AB_10015282 IRDye 800CW Donkey-anti-Mouse secondary antibody Li-COR 926-32212, RRID:AB_621847 IRDye 680RD Donkey-anti-Rabbit secondary antibody Li-COR 926-68073, RRID:AB_10954442 EZview Red Anti-HA Affinity Gel Sigma-Aldrich E6779-1ML, RRID:AB_10109562 EZview Red Anti-FLAG Affinity Gel Sigma-Aldrich F2426-1ML, RRID:AB_2616449 EZview Red GSH Affinity Gel Sigma-Aldrich E6406-1ML Chemicals, Peptides, and Recombinant Proteins CRL4 SpikeMix This study, synthesized by JPT Peptide Technologies, Berlin, Germany N/A CRL4 QconCAT This study, synthesized by PolyQuant GmbH, Bad Abbach, Germany N/A LysC protease Wako 125-02543 Trypsin protease Promega V511C MLN4924 Calbiochem 5.05477.0001 CSN5i-3 Custom synthesis N/A MLN7243 MedKoo Biosciences 206163 Bortezomib Selleck Chemicals S1013 CB5083 Custom synthesis N/A Indisulam MedKoo Biosciences 201540 Lenalidomide Selleck Chemicals S1029 (Continued on next page) e1 Molecular Cell 77, 1–15.e1–e9, March 5, 2020

Techniques: Immunoprecipitation, Control

Figure 3. Individual CRL4 Ligases Show Cullin-Scaffold Preferences and Differ up to 100-Fold in Absolute Abundance (A) Schematic of CRL4 QconCAT experiments to determine cellular concentrations and complex stoichiometries. (B–D) Absolute quantification of CRL4 components in whole cell lysates as well as immunoprecipitated Cul4 complexes. *Cul4 scaffolds were measured by targeting peptides common (cP) or unique (uP) to Cul4A and Cul4B. (E) Summary of cellular organization of CRL4 complexes. (F) and (G) Cellular concentrations of assembled CRL4s as well as DCAFs. (H) Correlation plot of percentage assembled (percentage of DCAF Cul4-bound versus free) and CRL4 ligase abundance (percentage of individual Cul4DCAF

Journal: Molecular cell

Article Title: PIKES Analysis Reveals Response to Degraders and Key Regulatory Mechanisms of the CRL4 Network.

doi: 10.1016/j.molcel.2019.12.013

Figure Lengend Snippet: Figure 3. Individual CRL4 Ligases Show Cullin-Scaffold Preferences and Differ up to 100-Fold in Absolute Abundance (A) Schematic of CRL4 QconCAT experiments to determine cellular concentrations and complex stoichiometries. (B–D) Absolute quantification of CRL4 components in whole cell lysates as well as immunoprecipitated Cul4 complexes. *Cul4 scaffolds were measured by targeting peptides common (cP) or unique (uP) to Cul4A and Cul4B. (E) Summary of cellular organization of CRL4 complexes. (F) and (G) Cellular concentrations of assembled CRL4s as well as DCAFs. (H) Correlation plot of percentage assembled (percentage of DCAF Cul4-bound versus free) and CRL4 ligase abundance (percentage of individual Cul4DCAF

Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Rabbit polyclonal anti-Cul4A (epitope Cell Signaling Technology 2699S, RRID:AB_2086563 Rabbit polyclonal anti-Cul4B (epitope AA Bethyl A303-863A, RRID:AB_2620214 Rabbit polyclonal anti-Cul4B (epitope AA Sigma-Aldrich C9995, RRID:AB_1840781 Mouse monoclonal anti-Cul1 (D-5) Santa Cruz Biotechnology Sc-17775, RRID:AB_627325 Rabbit polyclonal anti-Cand1 Bethyl A302-901A, RRID:AB_10663486 Rabbit monoclonal anti-DDB2 Abcam ab181136 Rabbit monoclonal anti-DDB1 Abcam ab109027, RRID:AB_10859111 Rabbit polyclonal anti-pCHK-1 Cell Signaling Technology 2341S, RRID:AB_330023 Rabbit polyclonal anti-pH2A.x Cell Signaling Technology 2577S, RRID:AB_2118010 Rabbit polyclonal anti-CRBN Sigma-Aldrich HPA045910-100UL, RRID:AB_10960409 Rabbit polyclonal anti-CSN5 Santa Cruz Biotechnology Sc-393725 Rat monoclonal anti-HA-HRP (clone 3F10) Roche 34071100 Mouse monoclonal anti-FLAG Sigma-Aldrich A8592-2MG, RRID:AB_439702 Mouse monoclonal anti-GAPDH Santa Cruz Biotechnology sc-365062, RRID:AB_10847862 Rabbit monoclonal anti-BRD4 Abcam ab128874, RRID:AB_11145462 Rabbit monoclonal anti-CK1alpha Abcam ab206662 Rabbit polyclonal anti-ZFP91 Bethyl A303-245A, RRID:AB_10953803 Rabbit polyclonal anti-RBM39 Bethyl A300-291A, RRID:AB_263411 Mouse monoclonlal anti-b-actin Sigma-Aldrich A5316, RRID:AB_476743 Rabbit monoclonal anti-GFP Abcam ab32146, RRID:AB_732717 Rabbit TrueBlot Anti-Rabbit IgG HRP Rockland 18-8816-33, RRID:AB_2610848 Donkey-anti-Mouse-HRP secondary antibody Jackson Laboratories 715-035-151, RRID:AB_2340771 Donkey anti-Rabbit-HRP secondary antibody Jackson Laboratories 711-035-152, RRID:AB_10015282 IRDye 800CW Donkey-anti-Mouse secondary antibody Li-COR 926-32212, RRID:AB_621847 IRDye 680RD Donkey-anti-Rabbit secondary antibody Li-COR 926-68073, RRID:AB_10954442 EZview Red Anti-HA Affinity Gel Sigma-Aldrich E6779-1ML, RRID:AB_10109562 EZview Red Anti-FLAG Affinity Gel Sigma-Aldrich F2426-1ML, RRID:AB_2616449 EZview Red GSH Affinity Gel Sigma-Aldrich E6406-1ML Chemicals, Peptides, and Recombinant Proteins CRL4 SpikeMix This study, synthesized by JPT Peptide Technologies, Berlin, Germany N/A CRL4 QconCAT This study, synthesized by PolyQuant GmbH, Bad Abbach, Germany N/A LysC protease Wako 125-02543 Trypsin protease Promega V511C MLN4924 Calbiochem 5.05477.0001 CSN5i-3 Custom synthesis N/A MLN7243 MedKoo Biosciences 206163 Bortezomib Selleck Chemicals S1013 CB5083 Custom synthesis N/A Indisulam MedKoo Biosciences 201540 Lenalidomide Selleck Chemicals S1029 (Continued on next page) e1 Molecular Cell 77, 1–15.e1–e9, March 5, 2020

Techniques: Immunoprecipitation

Lgl physically interacts with VprBP and DDB1 independently of Cul4A. (A) Lgl2 was immunoprecipitated from lysate prepared from confluently cultured MDCK cells. VprBP and DDB1 were coprecipitated with Lgl2, along with aPKC and PAR6β. (B) VprBP was immunoprecipitated from lysate prepared from confluently cultured MDCK cells. Lgl2, Lgl1, DDB1, and Cul4A were coprecipitated with VprBP, whereas aPKC and PAR6β were not. (C) VprBP was immunoprecipitated from control and Lgl1/2 KD MDCK cell lysate. Coimmunoprecipitation of Cul4A was up-regulated by depletion of Lgl1/2. (D) V5-VprBP deletion mutants and HA-Lgl2 were coexpressed in HEK293T cells. Immunoprecipitation was performed using anti-V5 antibody conjugated resin. Asterisk indicates the 110-kDa bands that were reproducibly detected in this experiment. VprBP may have an endo-cleavage site around amino acid 964. (E) Schematic representation of VprBP mutants and results of the experiment performed in D. Numbers in the left column represent amino acid number. Asterisk indicates position of amino acid 964. The binding site of Merlin, reported in Li et al. (2010) , is also illustrated. (F) VprBP was immunoprecipitated from the lysates of HEK293T cells transfected with SBP-Lgl2 expression vector (lanes 2 and 4) or SBP expression vector (lanes 1 and 3). Note that the amount of Cul4A coimmunoprecipitated with VprBP was significantly decreased by expression of Lgl2. (G) Coimmunoprecipitated DDB1 and Cul4A were quantified by densitometry, and the average of three independent experiments is plotted. Error bars indicate ±SD. Double asterisks denotes significant difference ( p < 0.01) by Student's t test. (H) VprBP or Cdt2 was immunoprecipitated from the common lysate of HEK293T cells transfected with SBP-Lgl2 expression vector (lanes 2, 4, 6, and 8) and also immunoprecipitated from the common lysate of cells transfected with SBP expression vector (lanes 1, 3, 5, and 7). Long-exposure image is also presented for Cul4A-immunoblot. (I) Hypothetical model for CRL4 [VprBP] and Lgl-VprBP-DDB1 complex. Lgl2 may sterically mask the Cul4A-binding domain of DDB1.

Journal: Molecular Biology of the Cell

Article Title: Tumor suppressor protein Lgl mediates G1 cell cycle arrest at high cell density by forming an Lgl-VprBP-DDB1 complex

doi: 10.1091/mbc.E14-10-1462

Figure Lengend Snippet: Lgl physically interacts with VprBP and DDB1 independently of Cul4A. (A) Lgl2 was immunoprecipitated from lysate prepared from confluently cultured MDCK cells. VprBP and DDB1 were coprecipitated with Lgl2, along with aPKC and PAR6β. (B) VprBP was immunoprecipitated from lysate prepared from confluently cultured MDCK cells. Lgl2, Lgl1, DDB1, and Cul4A were coprecipitated with VprBP, whereas aPKC and PAR6β were not. (C) VprBP was immunoprecipitated from control and Lgl1/2 KD MDCK cell lysate. Coimmunoprecipitation of Cul4A was up-regulated by depletion of Lgl1/2. (D) V5-VprBP deletion mutants and HA-Lgl2 were coexpressed in HEK293T cells. Immunoprecipitation was performed using anti-V5 antibody conjugated resin. Asterisk indicates the 110-kDa bands that were reproducibly detected in this experiment. VprBP may have an endo-cleavage site around amino acid 964. (E) Schematic representation of VprBP mutants and results of the experiment performed in D. Numbers in the left column represent amino acid number. Asterisk indicates position of amino acid 964. The binding site of Merlin, reported in Li et al. (2010) , is also illustrated. (F) VprBP was immunoprecipitated from the lysates of HEK293T cells transfected with SBP-Lgl2 expression vector (lanes 2 and 4) or SBP expression vector (lanes 1 and 3). Note that the amount of Cul4A coimmunoprecipitated with VprBP was significantly decreased by expression of Lgl2. (G) Coimmunoprecipitated DDB1 and Cul4A were quantified by densitometry, and the average of three independent experiments is plotted. Error bars indicate ±SD. Double asterisks denotes significant difference ( p < 0.01) by Student's t test. (H) VprBP or Cdt2 was immunoprecipitated from the common lysate of HEK293T cells transfected with SBP-Lgl2 expression vector (lanes 2, 4, 6, and 8) and also immunoprecipitated from the common lysate of cells transfected with SBP expression vector (lanes 1, 3, 5, and 7). Long-exposure image is also presented for Cul4A-immunoblot. (I) Hypothetical model for CRL4 [VprBP] and Lgl-VprBP-DDB1 complex. Lgl2 may sterically mask the Cul4A-binding domain of DDB1.

Article Snippet: Other antibodies were purchased as follows: Lgl2 (Abnova, Taipei, Taiwan), Lgl1 (Sigma-Aldrich, St. Louis, MO), VprBP (Proteintech Group, Chicago, IL), DDB1 (Bethyl, Montgomery, TX), Cul4A (Bethyl), Cul4B (Proteintech Group), Cdt2 (Novus Biologicals, Littleton, CO), PKC iota (BD, Franklin Lakes, NJ), zonula occludens-1 (ZO-1; Santa Cruz Biotechnology, Dallas, TX), p27kip1 (BD), p16INK4a (Cell Signaling, Danvers, MA), p21Waf1/Cip1 (Santa Cruz Biotechnology), Skp2 (Santa Cruz Biotechnology), Cdh1 (Abcam, Cambridge, United Kingdom), cyclin A (Santa Cruz Biotechnology), cyclin B1 (Santa Cruz Biotechnology), HSP70 (Enzo Life Sciences, Farmingdale NY), EDD1 (Bethyl), glyceraldehyde-3-phosphate dehydrogenase (Abcam), β-Actin (Sigma-Aldrich), E-cadherin (Sigma-Aldrich), V5 (Invitrogen), HA (Roche, Basel, Switzerland), SBP (Santa Cruz Biotechnology), Myc (Millipore, Billerica, MA; Cell Signaling), BrdU (BD; Abcam), and normal rabbit immunoglobulin G (Cell Signaling).

Techniques: Immunoprecipitation, Cell Culture, Control, Binding Assay, Transfection, Expressing, Plasmid Preparation, Western Blot

VprBP is involved in suppression of overproliferation mediated by Lgl. (A) MDCK cells were transfected with the indicated siRNAs, stained with PI, and subjected to flow cytometry. (B) MDCK cells were transfected with siRNAs for VprBP or DDB1 and cultured at low density. Knockdown of VprBP or DDB1 up-regulated p27 and down-regulated Skp2. (C) MDCK cells were transfected with two siRNAs targeting for Cul4A and Cul4B and cultured at low density. Asterisk denotes nonspecific signal. (D) VprBP and Cdh1 were simultaneously knocked down in MDCK cells. Note that knockdown of Cdh1 alleviated the effects of VprBP knockdown. (E) Control or Lgl1/2 KD MDCK cells were transfected with siRNA for VprBP. After culturing for 2 d, the amounts of Skp2 and p27 were analyzed. (F) Control or Lgl1/2 KD MDCK cells were transfected with nonsilencing siRNA (NS) or siRNA for VprBP and seeded confluently to Transwells. After culturing for 2 d, the BrdU incorporation assay was performed. (G) The ratio of BrdU-positive cells to total cells in the experiment in F was determined, and averages of three independent experiments are plotted. Error bars indicate ±SD. Asterisk denotes significant difference ( p < 0.05) by Student's t test. (H) Control or Lgl1/2 KD MDCK cells were transfected with nonsilencing siRNA (NS) or siRNA for VprBP and cultured until they reached confluency. Phase-contrast images and reconstituted confocal z -axis images of the epithelial sheets. Samples were stained with anti–ZO-1 (green), Alexa 647–phalloidin (red), and PI (blue). Scale bars, 10 μm (white), 30 μm (black). (I) The ratio of area of foci to total area was determined, and averages of three independent experiments are plotted. Error bars indicate ±SD. Note that knockdown of VprBP significantly suppressed formation of multilayered structures in Lgl1/2 KD MDCK cells. (J) Control or Lgl1/2 KD MDCK cells were transfected with nonsilencing siRNA (NS) or Cul4A siRNA 1 and Cul4B siRNA 1 and cultured until they reached confluency. Then the ratio of area of foci to total area was determined.

Journal: Molecular Biology of the Cell

Article Title: Tumor suppressor protein Lgl mediates G1 cell cycle arrest at high cell density by forming an Lgl-VprBP-DDB1 complex

doi: 10.1091/mbc.E14-10-1462

Figure Lengend Snippet: VprBP is involved in suppression of overproliferation mediated by Lgl. (A) MDCK cells were transfected with the indicated siRNAs, stained with PI, and subjected to flow cytometry. (B) MDCK cells were transfected with siRNAs for VprBP or DDB1 and cultured at low density. Knockdown of VprBP or DDB1 up-regulated p27 and down-regulated Skp2. (C) MDCK cells were transfected with two siRNAs targeting for Cul4A and Cul4B and cultured at low density. Asterisk denotes nonspecific signal. (D) VprBP and Cdh1 were simultaneously knocked down in MDCK cells. Note that knockdown of Cdh1 alleviated the effects of VprBP knockdown. (E) Control or Lgl1/2 KD MDCK cells were transfected with siRNA for VprBP. After culturing for 2 d, the amounts of Skp2 and p27 were analyzed. (F) Control or Lgl1/2 KD MDCK cells were transfected with nonsilencing siRNA (NS) or siRNA for VprBP and seeded confluently to Transwells. After culturing for 2 d, the BrdU incorporation assay was performed. (G) The ratio of BrdU-positive cells to total cells in the experiment in F was determined, and averages of three independent experiments are plotted. Error bars indicate ±SD. Asterisk denotes significant difference ( p < 0.05) by Student's t test. (H) Control or Lgl1/2 KD MDCK cells were transfected with nonsilencing siRNA (NS) or siRNA for VprBP and cultured until they reached confluency. Phase-contrast images and reconstituted confocal z -axis images of the epithelial sheets. Samples were stained with anti–ZO-1 (green), Alexa 647–phalloidin (red), and PI (blue). Scale bars, 10 μm (white), 30 μm (black). (I) The ratio of area of foci to total area was determined, and averages of three independent experiments are plotted. Error bars indicate ±SD. Note that knockdown of VprBP significantly suppressed formation of multilayered structures in Lgl1/2 KD MDCK cells. (J) Control or Lgl1/2 KD MDCK cells were transfected with nonsilencing siRNA (NS) or Cul4A siRNA 1 and Cul4B siRNA 1 and cultured until they reached confluency. Then the ratio of area of foci to total area was determined.

Article Snippet: Other antibodies were purchased as follows: Lgl2 (Abnova, Taipei, Taiwan), Lgl1 (Sigma-Aldrich, St. Louis, MO), VprBP (Proteintech Group, Chicago, IL), DDB1 (Bethyl, Montgomery, TX), Cul4A (Bethyl), Cul4B (Proteintech Group), Cdt2 (Novus Biologicals, Littleton, CO), PKC iota (BD, Franklin Lakes, NJ), zonula occludens-1 (ZO-1; Santa Cruz Biotechnology, Dallas, TX), p27kip1 (BD), p16INK4a (Cell Signaling, Danvers, MA), p21Waf1/Cip1 (Santa Cruz Biotechnology), Skp2 (Santa Cruz Biotechnology), Cdh1 (Abcam, Cambridge, United Kingdom), cyclin A (Santa Cruz Biotechnology), cyclin B1 (Santa Cruz Biotechnology), HSP70 (Enzo Life Sciences, Farmingdale NY), EDD1 (Bethyl), glyceraldehyde-3-phosphate dehydrogenase (Abcam), β-Actin (Sigma-Aldrich), E-cadherin (Sigma-Aldrich), V5 (Invitrogen), HA (Roche, Basel, Switzerland), SBP (Santa Cruz Biotechnology), Myc (Millipore, Billerica, MA; Cell Signaling), BrdU (BD; Abcam), and normal rabbit immunoglobulin G (Cell Signaling).

Techniques: Transfection, Staining, Flow Cytometry, Cell Culture, Knockdown, Control, BrdU Incorporation Assay

Lgl2-VprBP-DDB1 complex was well formed with reduction of CRL4 [VprBP] complex in confluent cells. (A) Lgl2 was immunoprecipitated from the lysates of MDCK cells cultured in confluent or low-density conditions. The amount of coprecipitated VprBP was higher from confluent cells. (B) VprBP was immunoprecipitated from MDCK cell lysates cultured in confluent or low-density conditions. The amount of coprecipitated Cul4A was lower from confluent cells. (C) Hypothetical model of Lgl-mediated inhibition of the CRL4 [VprBP] complex and its downstream pathway. Lgl forms a complex with VprBP-DDB1 independently of Cul4A when cells reach confluency. Lgl-VprBP-DDB1 complex is catalytically inactive because it lacks Cul4A and Roc1, the active center that associates with E2 enzyme.

Journal: Molecular Biology of the Cell

Article Title: Tumor suppressor protein Lgl mediates G1 cell cycle arrest at high cell density by forming an Lgl-VprBP-DDB1 complex

doi: 10.1091/mbc.E14-10-1462

Figure Lengend Snippet: Lgl2-VprBP-DDB1 complex was well formed with reduction of CRL4 [VprBP] complex in confluent cells. (A) Lgl2 was immunoprecipitated from the lysates of MDCK cells cultured in confluent or low-density conditions. The amount of coprecipitated VprBP was higher from confluent cells. (B) VprBP was immunoprecipitated from MDCK cell lysates cultured in confluent or low-density conditions. The amount of coprecipitated Cul4A was lower from confluent cells. (C) Hypothetical model of Lgl-mediated inhibition of the CRL4 [VprBP] complex and its downstream pathway. Lgl forms a complex with VprBP-DDB1 independently of Cul4A when cells reach confluency. Lgl-VprBP-DDB1 complex is catalytically inactive because it lacks Cul4A and Roc1, the active center that associates with E2 enzyme.

Article Snippet: Other antibodies were purchased as follows: Lgl2 (Abnova, Taipei, Taiwan), Lgl1 (Sigma-Aldrich, St. Louis, MO), VprBP (Proteintech Group, Chicago, IL), DDB1 (Bethyl, Montgomery, TX), Cul4A (Bethyl), Cul4B (Proteintech Group), Cdt2 (Novus Biologicals, Littleton, CO), PKC iota (BD, Franklin Lakes, NJ), zonula occludens-1 (ZO-1; Santa Cruz Biotechnology, Dallas, TX), p27kip1 (BD), p16INK4a (Cell Signaling, Danvers, MA), p21Waf1/Cip1 (Santa Cruz Biotechnology), Skp2 (Santa Cruz Biotechnology), Cdh1 (Abcam, Cambridge, United Kingdom), cyclin A (Santa Cruz Biotechnology), cyclin B1 (Santa Cruz Biotechnology), HSP70 (Enzo Life Sciences, Farmingdale NY), EDD1 (Bethyl), glyceraldehyde-3-phosphate dehydrogenase (Abcam), β-Actin (Sigma-Aldrich), E-cadherin (Sigma-Aldrich), V5 (Invitrogen), HA (Roche, Basel, Switzerland), SBP (Santa Cruz Biotechnology), Myc (Millipore, Billerica, MA; Cell Signaling), BrdU (BD; Abcam), and normal rabbit immunoglobulin G (Cell Signaling).

Techniques: Immunoprecipitation, Cell Culture, Inhibition

Figure 1. A Toolbox to Monitor Endogenous CRL4 Complexes Schematic representation of the PIKES approach: (1) 293T/17 cells were genetically engineered to carry a 3xFLAG or 3xHA on Cul4A or Cul4B or both to enable rapid and efficient (2) immunoprecipitation of endogenous CRL4 assemblages. (3) Endogenous CRL4 ligase complexes were then evaluated systematically using global and targeted proteomic approaches. First, the protein interaction network of interest was analyzed at endogenous protein levels, followed by a kinetic characterization of interactions, and the development of chemical and biochemical methods to control and preserve the composition of protein complexes. Subsequently, the cellular concentrations and complex stoichiometries were analyzed using QconCAT standards, and induced changes in complex composition were monitored quantitatively. See also Figures S1, S7, and S8.

Journal: Molecular cell

Article Title: PIKES Analysis Reveals Response to Degraders and Key Regulatory Mechanisms of the CRL4 Network.

doi: 10.1016/j.molcel.2019.12.013

Figure Lengend Snippet: Figure 1. A Toolbox to Monitor Endogenous CRL4 Complexes Schematic representation of the PIKES approach: (1) 293T/17 cells were genetically engineered to carry a 3xFLAG or 3xHA on Cul4A or Cul4B or both to enable rapid and efficient (2) immunoprecipitation of endogenous CRL4 assemblages. (3) Endogenous CRL4 ligase complexes were then evaluated systematically using global and targeted proteomic approaches. First, the protein interaction network of interest was analyzed at endogenous protein levels, followed by a kinetic characterization of interactions, and the development of chemical and biochemical methods to control and preserve the composition of protein complexes. Subsequently, the cellular concentrations and complex stoichiometries were analyzed using QconCAT standards, and induced changes in complex composition were monitored quantitatively. See also Figures S1, S7, and S8.

Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Rabbit polyclonal anti-Cul4A (epitope Cell Signaling Technology 2699S, RRID:AB_2086563 Rabbit polyclonal anti-Cul4B (epitope AA Bethyl A303-863A, RRID:AB_2620214 Rabbit polyclonal anti-Cul4B (epitope AA Sigma-Aldrich C9995, RRID:AB_1840781 Mouse monoclonal anti-Cul1 (D-5) Santa Cruz Biotechnology Sc-17775, RRID:AB_627325 Rabbit polyclonal anti-Cand1 Bethyl A302-901A, RRID:AB_10663486 Rabbit monoclonal anti-DDB2 Abcam ab181136 Rabbit monoclonal anti-DDB1 Abcam ab109027, RRID:AB_10859111 Rabbit polyclonal anti-pCHK-1 Cell Signaling Technology 2341S, RRID:AB_330023 Rabbit polyclonal anti-pH2A.x Cell Signaling Technology 2577S, RRID:AB_2118010 Rabbit polyclonal anti-CRBN Sigma-Aldrich HPA045910-100UL, RRID:AB_10960409 Rabbit polyclonal anti-CSN5 Santa Cruz Biotechnology Sc-393725 Rat monoclonal anti-HA-HRP (clone 3F10) Roche 34071100 Mouse monoclonal anti-FLAG Sigma-Aldrich A8592-2MG, RRID:AB_439702 Mouse monoclonal anti-GAPDH Santa Cruz Biotechnology sc-365062, RRID:AB_10847862 Rabbit monoclonal anti-BRD4 Abcam ab128874, RRID:AB_11145462 Rabbit monoclonal anti-CK1alpha Abcam ab206662 Rabbit polyclonal anti-ZFP91 Bethyl A303-245A, RRID:AB_10953803 Rabbit polyclonal anti-RBM39 Bethyl A300-291A, RRID:AB_263411 Mouse monoclonlal anti-b-actin Sigma-Aldrich A5316, RRID:AB_476743 Rabbit monoclonal anti-GFP Abcam ab32146, RRID:AB_732717 Rabbit TrueBlot Anti-Rabbit IgG HRP Rockland 18-8816-33, RRID:AB_2610848 Donkey-anti-Mouse-HRP secondary antibody Jackson Laboratories 715-035-151, RRID:AB_2340771 Donkey anti-Rabbit-HRP secondary antibody Jackson Laboratories 711-035-152, RRID:AB_10015282 IRDye 800CW Donkey-anti-Mouse secondary antibody Li-COR 926-32212, RRID:AB_621847 IRDye 680RD Donkey-anti-Rabbit secondary antibody Li-COR 926-68073, RRID:AB_10954442 EZview Red Anti-HA Affinity Gel Sigma-Aldrich E6779-1ML, RRID:AB_10109562 EZview Red Anti-FLAG Affinity Gel Sigma-Aldrich F2426-1ML, RRID:AB_2616449 EZview Red GSH Affinity Gel Sigma-Aldrich E6406-1ML Chemicals, Peptides, and Recombinant Proteins CRL4 SpikeMix This study, synthesized by JPT Peptide Technologies, Berlin, Germany N/A CRL4 QconCAT This study, synthesized by PolyQuant GmbH, Bad Abbach, Germany N/A LysC protease Wako 125-02543 Trypsin protease Promega V511C MLN4924 Calbiochem 5.05477.0001 CSN5i-3 Custom synthesis N/A MLN7243 MedKoo Biosciences 206163 Bortezomib Selleck Chemicals S1013 CB5083 Custom synthesis N/A Indisulam MedKoo Biosciences 201540 Lenalidomide Selleck Chemicals S1029 (Continued on next page) e1 Molecular Cell 77, 1–15.e1–e9, March 5, 2020

Techniques: Immunoprecipitation, Control

Figure 3. Individual CRL4 Ligases Show Cullin-Scaffold Preferences and Differ up to 100-Fold in Absolute Abundance (A) Schematic of CRL4 QconCAT experiments to determine cellular concentrations and complex stoichiometries. (B–D) Absolute quantification of CRL4 components in whole cell lysates as well as immunoprecipitated Cul4 complexes. *Cul4 scaffolds were measured by targeting peptides common (cP) or unique (uP) to Cul4A and Cul4B. (E) Summary of cellular organization of CRL4 complexes. (F) and (G) Cellular concentrations of assembled CRL4s as well as DCAFs. (H) Correlation plot of percentage assembled (percentage of DCAF Cul4-bound versus free) and CRL4 ligase abundance (percentage of individual Cul4DCAF

Journal: Molecular cell

Article Title: PIKES Analysis Reveals Response to Degraders and Key Regulatory Mechanisms of the CRL4 Network.

doi: 10.1016/j.molcel.2019.12.013

Figure Lengend Snippet: Figure 3. Individual CRL4 Ligases Show Cullin-Scaffold Preferences and Differ up to 100-Fold in Absolute Abundance (A) Schematic of CRL4 QconCAT experiments to determine cellular concentrations and complex stoichiometries. (B–D) Absolute quantification of CRL4 components in whole cell lysates as well as immunoprecipitated Cul4 complexes. *Cul4 scaffolds were measured by targeting peptides common (cP) or unique (uP) to Cul4A and Cul4B. (E) Summary of cellular organization of CRL4 complexes. (F) and (G) Cellular concentrations of assembled CRL4s as well as DCAFs. (H) Correlation plot of percentage assembled (percentage of DCAF Cul4-bound versus free) and CRL4 ligase abundance (percentage of individual Cul4DCAF

Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Rabbit polyclonal anti-Cul4A (epitope Cell Signaling Technology 2699S, RRID:AB_2086563 Rabbit polyclonal anti-Cul4B (epitope AA Bethyl A303-863A, RRID:AB_2620214 Rabbit polyclonal anti-Cul4B (epitope AA Sigma-Aldrich C9995, RRID:AB_1840781 Mouse monoclonal anti-Cul1 (D-5) Santa Cruz Biotechnology Sc-17775, RRID:AB_627325 Rabbit polyclonal anti-Cand1 Bethyl A302-901A, RRID:AB_10663486 Rabbit monoclonal anti-DDB2 Abcam ab181136 Rabbit monoclonal anti-DDB1 Abcam ab109027, RRID:AB_10859111 Rabbit polyclonal anti-pCHK-1 Cell Signaling Technology 2341S, RRID:AB_330023 Rabbit polyclonal anti-pH2A.x Cell Signaling Technology 2577S, RRID:AB_2118010 Rabbit polyclonal anti-CRBN Sigma-Aldrich HPA045910-100UL, RRID:AB_10960409 Rabbit polyclonal anti-CSN5 Santa Cruz Biotechnology Sc-393725 Rat monoclonal anti-HA-HRP (clone 3F10) Roche 34071100 Mouse monoclonal anti-FLAG Sigma-Aldrich A8592-2MG, RRID:AB_439702 Mouse monoclonal anti-GAPDH Santa Cruz Biotechnology sc-365062, RRID:AB_10847862 Rabbit monoclonal anti-BRD4 Abcam ab128874, RRID:AB_11145462 Rabbit monoclonal anti-CK1alpha Abcam ab206662 Rabbit polyclonal anti-ZFP91 Bethyl A303-245A, RRID:AB_10953803 Rabbit polyclonal anti-RBM39 Bethyl A300-291A, RRID:AB_263411 Mouse monoclonlal anti-b-actin Sigma-Aldrich A5316, RRID:AB_476743 Rabbit monoclonal anti-GFP Abcam ab32146, RRID:AB_732717 Rabbit TrueBlot Anti-Rabbit IgG HRP Rockland 18-8816-33, RRID:AB_2610848 Donkey-anti-Mouse-HRP secondary antibody Jackson Laboratories 715-035-151, RRID:AB_2340771 Donkey anti-Rabbit-HRP secondary antibody Jackson Laboratories 711-035-152, RRID:AB_10015282 IRDye 800CW Donkey-anti-Mouse secondary antibody Li-COR 926-32212, RRID:AB_621847 IRDye 680RD Donkey-anti-Rabbit secondary antibody Li-COR 926-68073, RRID:AB_10954442 EZview Red Anti-HA Affinity Gel Sigma-Aldrich E6779-1ML, RRID:AB_10109562 EZview Red Anti-FLAG Affinity Gel Sigma-Aldrich F2426-1ML, RRID:AB_2616449 EZview Red GSH Affinity Gel Sigma-Aldrich E6406-1ML Chemicals, Peptides, and Recombinant Proteins CRL4 SpikeMix This study, synthesized by JPT Peptide Technologies, Berlin, Germany N/A CRL4 QconCAT This study, synthesized by PolyQuant GmbH, Bad Abbach, Germany N/A LysC protease Wako 125-02543 Trypsin protease Promega V511C MLN4924 Calbiochem 5.05477.0001 CSN5i-3 Custom synthesis N/A MLN7243 MedKoo Biosciences 206163 Bortezomib Selleck Chemicals S1013 CB5083 Custom synthesis N/A Indisulam MedKoo Biosciences 201540 Lenalidomide Selleck Chemicals S1029 (Continued on next page) e1 Molecular Cell 77, 1–15.e1–e9, March 5, 2020

Techniques: Immunoprecipitation